Can you share a specific case that exemplifies at least one clinical phenotype with MAC lung disease that is appropriately managed with amikacin liposome inhaled suspension?

Can you share a specific case that exemplifies at least one clinical phenotype with MAC lung disease that is appropriately managed with amikacin liposome inhaled suspension?

Can you share a specific case that exemplifies at least one clinical phenotype with MAC lung disease that is appropriately managed with amikacin liposome inhaled suspension?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Shannon Kasperbauer, MD

Shannon Kasperbauer, MD

Associate Professor of Medicine
Department of Medicine
Division of Mycobacterial & Respiratory Infections
National Jewish
Denver, Colorado